These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 10634801

  • 1. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH, Köhler T, Rückschloss U, Just I, Hecker M.
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [Abstract] [Full Text] [Related]

  • 2. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
    Vecchione C, Brandes RP.
    Circ Res; 2002 Jul 26; 91(2):173-9. PubMed ID: 12142351
    [Abstract] [Full Text] [Related]

  • 3. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH, Schwabe O, Hecker M.
    Br J Pharmacol; 2002 May 26; 136(1):143-9. PubMed ID: 11976279
    [Abstract] [Full Text] [Related]

  • 4. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
    Parker RA, Huang Q, Tesfamariam B.
    Atherosclerosis; 2003 Jul 26; 169(1):19-29. PubMed ID: 12860247
    [Abstract] [Full Text] [Related]

  • 5. Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.
    Alvarez De Sotomayor M, Herrera MD, Marhuenda E, Andriantsitohaina R.
    Br J Pharmacol; 2000 Nov 26; 131(6):1179-87. PubMed ID: 11082126
    [Abstract] [Full Text] [Related]

  • 6. Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin.
    Christ M, Bauersachs J, Liebetrau C, Heck M, Günther A, Wehling M.
    Diabetes; 2002 Aug 26; 51(8):2648-52. PubMed ID: 12145183
    [Abstract] [Full Text] [Related]

  • 7. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
    Feron O, Dessy C, Desager JP, Balligand JL.
    Circulation; 2001 Jan 02; 103(1):113-8. PubMed ID: 11136695
    [Abstract] [Full Text] [Related]

  • 8. Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin.
    Kalinowski L, Dobrucki LW, Brovkovych V, Malinski T.
    Circulation; 2002 Feb 26; 105(8):933-8. PubMed ID: 11864921
    [Abstract] [Full Text] [Related]

  • 9. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH, Gebauer M, Güldenzoph B, Hecker M.
    Arterioscler Thromb Vasc Biol; 2002 Nov 01; 22(11):1784-9. PubMed ID: 12426205
    [Abstract] [Full Text] [Related]

  • 10. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D, Hayashi T, Thakur NK, Jayachandran M, Asai Y, Kano H, Matsui H, Iguchi A.
    Atherosclerosis; 2001 Apr 01; 155(2):347-57. PubMed ID: 11254905
    [Abstract] [Full Text] [Related]

  • 11. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S, Laufs U, Bäumer AT, Müller K, Ahlbory K, Linz W, Itter G, Rösen R, Böhm M, Nickenig G.
    Hypertension; 2001 Jun 01; 37(6):1450-7. PubMed ID: 11408394
    [Abstract] [Full Text] [Related]

  • 12. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J, Kathirvel K, Leo MD, Kuntamallappanavar G, Uttam Singh T, Mishra SK.
    J Cardiovasc Pharmacol; 2009 Dec 01; 54(6):526-34. PubMed ID: 19755915
    [Abstract] [Full Text] [Related]

  • 13. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
    Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang MH, Tousoulis D, Antonopoulos AS, Demosthenous M, Marinou K, Hale A, Paschalis A, Psarros C, Triantafyllou C, Bendall J, Casadei B, Stefanadis C, Channon KM.
    Circulation; 2011 Jul 19; 124(3):335-45. PubMed ID: 21730307
    [Abstract] [Full Text] [Related]

  • 14. Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta.
    Deng HF, Xiong Y.
    Acta Pharmacol Sin; 2005 Jan 19; 26(1):92-8. PubMed ID: 15659120
    [Abstract] [Full Text] [Related]

  • 15. Prevention of nitrate tolerance by long-term treatment with statins.
    Fontaine D, Otto A, Fontaine J, Berkenboom G.
    Cardiovasc Drugs Ther; 2003 Mar 19; 17(2):123-8. PubMed ID: 12975593
    [Abstract] [Full Text] [Related]

  • 16. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.
    Okamura T, Tawa M, Geddawy A, Shimosato T, Iwasaki H, Shintaku H, Yoshida Y, Masada M, Shinozaki K, Imamura T.
    J Pharmacol Sci; 2014 Mar 19; 124(1):76-85. PubMed ID: 24389820
    [Abstract] [Full Text] [Related]

  • 17. Relaxant effects of pravastatin, atorvastatin and cerivastatin on isolated rat aortic rings.
    Sönmez Uydeş-Doğan B, Topal G, Takir S, Ilkay Alp F, Kaleli D, Ozdemir O.
    Life Sci; 2005 Feb 25; 76(15):1771-86. PubMed ID: 15698855
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.
    Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, Förstermann U, Münzel T.
    Atherosclerosis; 2008 May 25; 198(1):65-76. PubMed ID: 18061195
    [Abstract] [Full Text] [Related]

  • 19. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC, Ahmed Z, Mankoff R, Lidington EA, Ahmad S, Bhatia V, Kinderlerer A, Randi AM, Haskard DO.
    Circ Res; 2002 Oct 18; 91(8):696-703. PubMed ID: 12386146
    [Abstract] [Full Text] [Related]

  • 20. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z, Guerard P, Lirussi F, Goirand F, Rochette L, Dumas M, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec 18; 374(3):195-206. PubMed ID: 17102939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.